Skip to main content

Table 3 Multivariate analysis

From: Haploidentical related donor compared to HLA-identical donor transplantation for chemosensitive Hodgkin lymphoma patients

  HR (CI95%) P value
PFS
 Disease status (CR vs PR) 0.51 (0.34–0.75) < 0.001
 Haplo vs HLAid 0.56 (0.35–0.89) 0.014
OS
 Disease status (CR vs PR) 0.57 (0.35–0.93) 0.023
 Age (continuous variable) 0.04 (1.00–1.05) 0.043
Relapse
 Haplo vs HLAid 0.37 (0.23–0.60) < 0.001
 Disease status (CR vs PR) 0.43 (0.43–0.79) 0.006
  1. CR complete remission, PR partial remission, PFS progression free survival, OS overall survival
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us

\